Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Glucose Control”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00121667
What this trial is testing

Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 1,462
Large-scale testing (Phase 3)Study completedNCT03351478
What this trial is testing

Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 770
Large-scale testing (Phase 3)Ended earlyNCT03608358
What this trial is testing

Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 41
Testing effectiveness (Phase 2)Study completedNCT01111955
What this trial is testing

Safety Study of BMS-823778 in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Bristol-Myers Squibb 62
Large-scale testing (Phase 3)Study completedNCT00086502
What this trial is testing

Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 353
Testing effectiveness (Phase 2)Study completedNCT00972244
What this trial is testing

Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 417
Large-scale testing (Phase 3)Study completedNCT03717194
What this trial is testing

Effect of Ertugliflozin on Cardiac Function in Diabetes

Who this might be right for
Type2 DiabetesHeart Failure
Soo Lim 102
Large-scale testing (Phase 3)Study completedNCT01137812
What this trial is testing

The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 756
Large-scale testing (Phase 3)Ended earlyNCT01678820
What this trial is testing

The Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 299
Large-scale testing (Phase 3)Study completedNCT01183013
What this trial is testing

30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 Weeks

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 936
Large-scale testing (Phase 3)Study completedNCT06192108
What this trial is testing

Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 962
Post-approval studies (Phase 4)Study completedNCT02231021
What this trial is testing

The Practical Evidence of Antidiabetic Combination Therapy in Korea

Who this might be right for
Type 2 Diabetes Mellitus
Kun-Ho Yoon 216
Post-approval studies (Phase 4)Study completedNCT01864174
What this trial is testing

Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Bristol-Myers Squibb 1,736
Testing effectiveness (Phase 2)Study completedNCT01193218
What this trial is testing

Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 547
Large-scale testing (Phase 3)Study completedNCT00601250
What this trial is testing

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 701
Large-scale testing (Phase 3)Study completedNCT01999218
What this trial is testing

Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 1,326
Large-scale testing (Phase 3)WithdrawnNCT01984606
What this trial is testing

Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim
Large-scale testing (Phase 3)Study completedNCT03285594
What this trial is testing

Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking Insulin Alone or With Other Oral Antidiabetic Agents

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 571
Not applicableStudy completedNCT00945659
What this trial is testing

Use of Continuous Glucose Sensors by Adolescents With Inadequate Diabetic Control

Who this might be right for
Type 1 Diabetes Mellitus
Nemours Children's Clinic 116
Post-approval studies (Phase 4)Study completedNCT00118963
What this trial is testing

Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Steno Diabetes Center Copenhagen 102
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation